Transcatheter aortic and mitral valve interventions: Update 2010
Standard
Transcatheter aortic and mitral valve interventions: Update 2010. / Conradi, Lenard; Treede, Hendrik; Franzen, Olaf; Seiffert, Moritz; Baldus, Stephan; Schirmer, Johannes; Meinertz, Thomas; Reichenspurner, Hermann.
in: Interventional Cardiology, Jahrgang 2, Nr. 4, 08.2010, S. 513-523.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Transcatheter aortic and mitral valve interventions: Update 2010
AU - Conradi, Lenard
AU - Treede, Hendrik
AU - Franzen, Olaf
AU - Seiffert, Moritz
AU - Baldus, Stephan
AU - Schirmer, Johannes
AU - Meinertz, Thomas
AU - Reichenspurner, Hermann
PY - 2010/8
Y1 - 2010/8
N2 - In recent years, the cardiovascular community has witnessed the advent of new, transcatheter-based beating-heart approaches to valvular heart disease. Since the mid-1980s, when balloon valvuloplasty of stenosed aortic valves and percutaneous commissurotomy in mitral stenosis were introduced into clinical practice, interventional valve therapy has seen a tremendous upsurge. Today, transcatheter aortic valve implantation has become a viable treatment alternative for selective cases at specialized centers. While transcatheter aortic valve implantation is currently restricted to high-risk patients and surgical aortic valve replacement remains the reference treatment, broader clinical application can be anticipated for the future. Nonsurgical intervention for treatment of mitral regurgitation is a second field of intense investigation. The growing incidence of congestive heart failure in western societies has created an unmet clinical need for less invasive treatment strategies for patients with functional or organic mitral regurgitation. This article summarizes the current state of transcatheter aortic and mitral valve interventions and discusses future perspectives.
AB - In recent years, the cardiovascular community has witnessed the advent of new, transcatheter-based beating-heart approaches to valvular heart disease. Since the mid-1980s, when balloon valvuloplasty of stenosed aortic valves and percutaneous commissurotomy in mitral stenosis were introduced into clinical practice, interventional valve therapy has seen a tremendous upsurge. Today, transcatheter aortic valve implantation has become a viable treatment alternative for selective cases at specialized centers. While transcatheter aortic valve implantation is currently restricted to high-risk patients and surgical aortic valve replacement remains the reference treatment, broader clinical application can be anticipated for the future. Nonsurgical intervention for treatment of mitral regurgitation is a second field of intense investigation. The growing incidence of congestive heart failure in western societies has created an unmet clinical need for less invasive treatment strategies for patients with functional or organic mitral regurgitation. This article summarizes the current state of transcatheter aortic and mitral valve interventions and discusses future perspectives.
KW - aortic stenosis
KW - aortic valve replacement
KW - mitral regurgitation
KW - mitral valve repair
KW - percutaneous
KW - transcatheter
UR - http://www.scopus.com/inward/record.url?scp=77956159169&partnerID=8YFLogxK
U2 - 10.2217/ica.10.47
DO - 10.2217/ica.10.47
M3 - SCORING: Review article
AN - SCOPUS:77956159169
VL - 2
SP - 513
EP - 523
IS - 4
ER -